ESSA Pharma Future Growth

How is ESSA Pharma forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


14.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:EPIX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202510-76-144N/A4
9/30/2024N/A-67-108N/A4
9/30/2023N/A-48-59N/A4
9/30/2022N/A-35-29-29N/A
6/30/2022N/A-37-28-28N/A
3/31/2022N/A-37-28-28N/A
12/31/2021N/A-39-27-27N/A
9/30/2021N/A-37-25-25N/A
6/30/2021N/A-33-22-22N/A
3/31/2021N/A-29-19-19N/A
12/31/2020N/A-25-18-18N/A
9/30/2020N/A-23-17-17N/A
6/30/2020N/A-22-18-18N/A
3/31/2020N/A-21-17-17N/A
12/31/2019N/A-15-14-14N/A
9/30/2019N/A-13-12-12N/A
6/30/2019N/A-12-9-9N/A
3/31/2019N/A-11-10-10N/A
12/31/2018N/A-12-10-10N/A
9/30/2018N/A-12-10-10N/A
6/30/2018N/A-11-11-11N/A
3/31/2018N/A-5-13-13N/A
12/31/2017N/A-8-13-13N/A
9/30/2017N/A-4-17-17N/A
6/30/2017N/A-7-18-18N/A
3/31/2017N/A-14-16-16N/A
12/31/2016N/A-8-19-19N/A
9/30/2016N/A-13-15-15N/A
6/30/2016N/A-8N/A-17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EPIX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: EPIX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: EPIX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: EPIX is forecast to have no revenue next year.

High Growth Revenue: EPIX is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EPIX's Return on Equity is forecast to be high in 3 years time


Discover growth companies